Obliteride Funding in Action

In 2017, Obliteride raised $2.8 million for cancer research at Fred Hutch. Cures start here — because of you.
Obliteride funds research in the areas of greatest need at Fred Hutch. From Basic Sciences and Public Health to deep exploration into organ-specific cancers and immunotherapy, we've funded over $12 million in research over the past four years. The areas we've been able to impact, with the dollars you've raised and/or donated in 2017, include:

HUTCH RESEARCHERS POWERED BY 2017 OBLITERIDE

JESSE D. BLOOM, PhD

EMILY HATCH, PhD

Hatch,-E.jpg
Hatch Lab
Biology of the Nucleus
What The Hatch Lab Does
CECILIA MOENS, PhD
Cell Development Neurobiology
Imune cells share their inside with tumors to promote cancer spread
ROLAND STRONG, PhD

Strong,-R-(2).jpg
Strong Lab
Translational Biophysics, Structural Molecular Immunology and Vaccinology
New technological platform opens unexplored world of tiny proteins
JENNIFER ADAIR, PhD

Adair,-J-(1).jpg
Adair Lab
PAUL CARPENTER, MD.BS

Carpenter,-P.jpg
Lymphoma and Leukemia

 
RACHEL CEBALLOS, PhD

Ceballos,-R.jpg
Ceballos Lab
KEVIN CHEUNG, MD, PhD

Cheung,-K.jpg
Cheung Lab